Acellular DTP vaccine produces fewer reactions
Boletin de la Asociacion Medica de Puerto Rico 80(11): 440-441
1988
ISSN/ISBN: 0004-4849 PMID: 3265325 Document Number: 700204
Document emailed within 1 workday
Related Documents
Deloria, M.A.; Blackwelder, W.C.; Decker, M.D.; Englund, J.A.; Steinhoff, M.C.; Pichichero, M.E.; Rennels, M.B.; Anderson, E.L.; Edwards, K.M. 1995: Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations Pediatrics 96(3 Pt 2): 592-594Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Kaijser, B. 1988: Should acellular pertussis vaccine be introduced into Sweden? Lakartidningen 85(42): 3447
1992: ACIP issues statement on acellular pertussis vaccine American Family Physician 46(1): 286 291
Egorova, N.B.; Efremova, V.N.; Kurbatova, E.A.; Gruber, I.M. 2008: Experimental, clinical and immunologic assessment of acellular staphylococcal vaccine "Staphylovac" Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 102-108
Dias, W.O.; Horton, D.S.; Takahashi, C.M.; Raw, I. 1994: A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction Brazilian Journal of Medical and Biological Research 27(11): 2607-2611
Giammanco, G.; Pignato, S.; Taormina, S.; Genovese, M.; Maggio, M.; Giammanco, A.; Anfuso, S.; Pittalà, D.; Li Volti, S.; Soncini, R. 1997: Immunization efficacy and tolerance of a tetravalent vaccine against diphtheria, tetanus, pertussis (acellular) and hepatitis B Annali di Igiene: Medicina Preventiva e di Comunita 9(3): 209-213
Isomura, S. 1991: Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan Developments in Biological Standardization 73: 37-42
Trotter, A.C.; Stone, B.D.; Laszlo, D.J.; Georgitis, J.W. 1994: Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization Annals of Allergy 72(1): 25-28
1997: From the Centers for Disease Control and Prevention. FDA approval of a second acellular pertussis vaccine for use among infants and young children JAMA 277(10): 783
Bose, A.; Dubey, A.P.; Gandhi, D.; Pandit, A.; Raghu, M.B.; Raghupathy, P.; Rao, M.I.S.; Verghese, V.P.; Datta, S.K.; Bock, H.L. 2007: Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children Indian Pediatrics 44(6): 421-424
Abarca, K.; Valdivieso, F.; Potin, M.; Ibáñez, I.; Vial, P. 2002: Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults Revista Medica de Chile 130(5): 502-510
Chan, S.H.; Tan, P.T.N.; Han, H.H.; Bock, H.L. 2006: Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults Singapore Medical Journal 47(4): 286-290
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105